Residency · Scottsdale, AZ
Sponsored by Mayo Clinic College of Medicine and Science
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Lancet (London, England) · 2023 · 223 citations · Lynne Napatalung
Akkermansia muciniphila phospholipid induces homeostatic immune responses.
Nature · 2022 · 345 citations · Stella Chen
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Blood · 2022 · 147 citations · Mark Pittelkow
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
JAMA oncology · 2022 · 123 citations · Bianca Kang
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet (London, England) · 2025 · 44 citations · Aaron Mangold
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2025 · 36 citations · Hannah Godfrey
Prevalence of Vitiligo Among Adults in the United States.
JAMA dermatology · 2022 · 84 citations · Lynne Napatalung
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection.
JAMA dermatology · 2021 · 77 citations · Bianca Kang